• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Biologic Therapies in HIV-infected Patients with Psoriasis: An Italian Experience.

作者信息

Bardazzi Federico, Magnano Michela, Campanati Anna, Loconsole Francesco, Carpentieri Antonio, Potenza Concetta, Bernardini Nicoletta, Di Lernia Vito, Carrera Carlo, Raone Beatrice, Patrizi Annalisa, Loi Camilla

机构信息

Department of Specialized, Clinical and Experimental Medicine, Division of Dermatology, University of Bologna, Via Massarenti 1, IT-40138 Bologna, Italy.

出版信息

Acta Derm Venereol. 2017 Aug 31;97(8):989-990. doi: 10.2340/00015555-2698.

DOI:10.2340/00015555-2698
PMID:28512671
Abstract
摘要

相似文献

1
Biologic Therapies in HIV-infected Patients with Psoriasis: An Italian Experience.HIV感染的银屑病患者的生物疗法：意大利的经验。
Acta Derm Venereol. 2017 Aug 31;97(8):989-990. doi: 10.2340/00015555-2698.
2
Down-titration of Adalimumab and Etanercept in Psoriatic Patients: A Multicentre Observational Study.银屑病患者中阿达木单抗和依那西普的减量治疗：一项多中心观察性研究。
Acta Derm Venereol. 2016 Feb;96(2):251-2. doi: 10.2340/00015555-2209.
3
Safety and efficacy of biological therapies in patients with psoriasis with alcoholic cirrhosis: a French retrospective study of 23 cases.生物疗法对合并酒精性肝硬化的银屑病患者的安全性和有效性：一项针对23例患者的法国回顾性研究
Br J Dermatol. 2018 Aug;179(2):512-513. doi: 10.1111/bjd.16490. Epub 2018 Jun 21.
4
Thrombocytopenia in a psoriatic patient sequentially treated with adalimumab, secukinumab and ustekinumab.一名银屑病患者先后接受阿达木单抗、司库奇尤单抗和优特克单抗治疗后出现血小板减少症。
J Dermatol. 2019 May;46(5):e157-e158. doi: 10.1111/1346-8138.14681. Epub 2018 Oct 24.
5
Prolongation of Biologic Dosing Intervals in Patients With Stable Psoriasis: A Feasibility Study.稳定型银屑病患者生物制剂给药间隔的延长：一项可行性研究。
Ther Drug Monit. 2017 Aug;39(4):379-386. doi: 10.1097/FTD.0000000000000420.
6
Biologic drug survival in Israeli psoriasis patients.以色列银屑病患者的生物药物存活情况。
J Am Acad Dermatol. 2017 Apr;76(4):662-669.e1. doi: 10.1016/j.jaad.2016.10.033. Epub 2016 Dec 28.
7
Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR]).在真实环境中治疗银屑病的生物制剂的比较疗效：一项大型前瞻性观察研究（银屑病纵向评估和登记研究 [PSOLAR]）的结果。
J Am Acad Dermatol. 2016 May;74(5):851-61.e4. doi: 10.1016/j.jaad.2015.12.017. Epub 2016 Feb 4.
8
Real-world efficacy of biological agents in moderate-to-severe plaque psoriasis: An analysis of 75 patients in Taiwan.真实世界中生物制剂治疗中重度斑块状银屑病的疗效：对台湾 75 例患者的分析。
PLoS One. 2020 Dec 29;15(12):e0244620. doi: 10.1371/journal.pone.0244620. eCollection 2020.
9
Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry.在日常临床实践中比较阿达木单抗、依那西普和乌司奴单抗治疗银屑病患者的 1 年和 5 年疗效：来自前瞻性 BioCAPTURE 登记研究的结果。
Br J Dermatol. 2017 Apr;176(4):1001-1009. doi: 10.1111/bjd.15023. Epub 2017 Mar 10.
10
Etanercept, adalimumab, and ustekinumab in psoriasis: analysis of 209 treatment series in Austria.依那西普、阿达木单抗和优特克单抗治疗银屑病：奥地利209个治疗系列分析
J Dtsch Dermatol Ges. 2017 Mar;15(3):309-317. doi: 10.1111/ddg.13191. Epub 2017 Feb 27.

引用本文的文献

1
Exploring the Impact of Guselkumab and Risankizumab on Psoriasis in HIV-Positive Patients: Insights From Four Italian Centers.探索古塞库单抗和司库奇尤单抗对HIV阳性患者银屑病的影响：来自四个意大利中心的见解
Australas J Dermatol. 2025 Jun;66(4):215-219. doi: 10.1111/ajd.14467. Epub 2025 Apr 3.
2
Systematic review of biologic use for psoriasis in HIV-positive individuals from 2018 to 2024.2018 年至 2024 年 HIV 阳性个体银屑病生物制剂应用的系统评价。
Arch Dermatol Res. 2024 Nov 13;317(1):14. doi: 10.1007/s00403-024-03395-1.
3
Infections in the era of immunobiologicals.
免疫生物制剂时代的感染。
An Bras Dermatol. 2024 Mar-Apr;99(2):167-180. doi: 10.1016/j.abd.2023.08.004. Epub 2024 Jan 17.
4
Advancements in the Study of Biologic Agents in Comorbidities of Psoriasis: A Literature Review.银屑病合并症生物制剂研究进展：文献综述
Clin Cosmet Investig Dermatol. 2023 Dec 4;16:3487-3495. doi: 10.2147/CCID.S439110. eCollection 2023.
5
New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate.一种古老药物的新视野与旧视野：富马酸二甲酯的药代动力学、药效学及临床展望
Pharmaceutics. 2022 Dec 6;14(12):2732. doi: 10.3390/pharmaceutics14122732.
6
Mesenchymal Stem Cells and Psoriasis: Systematic Review.间充质干细胞与银屑病：系统综述。
Int J Mol Sci. 2022 Dec 1;23(23):15080. doi: 10.3390/ijms232315080.
7
Hidradenitis Suppurativa in Patients with HIV: A Scoping Review.HIV患者的化脓性汗腺炎：一项范围综述。
Biomedicines. 2022 Oct 31;10(11):2761. doi: 10.3390/biomedicines10112761.
8
A Systematic Review of Atopic Dermatitis: The Intriguing Journey Starting from Physiopathology to Treatment, from Laboratory Bench to Bedside.特应性皮炎的系统评价：从病理生理学到治疗，从实验室工作台到床边的迷人之旅。
Biomedicines. 2022 Oct 25;10(11):2700. doi: 10.3390/biomedicines10112700.
9
Mesenchymal Stem Cells Profile in Adult Atopic Dermatitis and Effect of IL4-IL13 Inflammatory Pathway Inhibition In Vivo: Prospective Case-Control Study.成人特应性皮炎中间充质干细胞概况及体内IL4-IL13炎症通路抑制作用：前瞻性病例对照研究
J Clin Med. 2022 Aug 15;11(16):4759. doi: 10.3390/jcm11164759.
10
Biologic Treatment of 4 HIV-Positive Patients: A Case Series and Literature Review.4例HIV阳性患者的生物治疗：病例系列及文献综述
J Psoriasis Psoriatic Arthritis. 2021 Jan;6(1):19-26. doi: 10.1177/2475530320954279. Epub 2020 Sep 16.